Cosmetic, not medical
Semaglutide May Be Considered When A patient is an appropriate candidate for GLP-1 therapy and needs medical support for appetite, weight, blood sugar, and cardiometabolic risk
John Burns Semaglutide-based weight loss treatments, like Ozempic, have revolutionized weight loss, allowing patients to shed pounds rapidly
Accepting Cases Across the United States While based in Houston, Texas, Reich & Binstock accepts Ozempic lawsuits and other pharmaceutical injury cases from clients nationwide
GLP-1 medications like semaglutide are not recommended for individuals with a history of: Medullary thyroid carcinoma (or a family history of it) Multiple endocrine neoplasia syndrome type 2 (MEN 2) Pancreatitis or gallbladder disease Severe gastrointestinal disorders FuturHealth clinicians screen all patients for these risk factors during the onboarding process
Customized Weight loss treatment plans are available depending on your goals and method of losing weight